These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3785961)

  • 1. Prolonged survival in multiple myeloma.
    Viswanathan B; Sayson LM
    Pa Med; 1986 Nov; 89(11):50, 52. PubMed ID: 3785961
    [No Abstract]   [Full Text] [Related]  

  • 2. Unusual morphologic presentation of plasma cells during the course of a multiple myeloma.
    Salignac S; Buisine J; Lesesve JF
    Haematologica; 2004 Apr; 89(4):EIM04. PubMed ID: 15075107
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma and bone.
    Chappard D
    Morphologie; 2015 Jun; 99(325):29-30. PubMed ID: 25952499
    [No Abstract]   [Full Text] [Related]  

  • 4. Auer rod-like intracytoplasmic inclusions in multiple myeloma. A case report and review of the literature.
    Hütter G; Nowak D; Blau IW; Thiel E
    Int J Lab Hematol; 2009 Apr; 31(2):236-40. PubMed ID: 18190590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
    Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
    Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
    Galani Z; Viniou N; Kyrtsonis MC; Sachanas S; Antoniou T; Dimopoulou MN; Vassilakopoulos TP; Korkolopoulou P; Nakopoulou L; Patsouris E; Pangalis GA
    Anticancer Res; 2007; 27(1B):571-4. PubMed ID: 17348443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myeloma.
    Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Horak P; Minarik J
    Haematologica; 2005 Dec; 90(12):1713-4. PubMed ID: 16330455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical bone changes in a case of multiple myeloma with long survival].
    Aro A; Vuopio P
    Duodecim; 1966; 82(22):1112-6. PubMed ID: 5959233
    [No Abstract]   [Full Text] [Related]  

  • 11. [The osteocondensing variety of multiple myeloma. Review of the literature and description of a case].
    Coscia GC; Angela GC; Discalzi GL
    Minerva Med; 1983 Oct; 74(41):2471-9. PubMed ID: 6646480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of multiple myeloma.
    Alexanian R; Dimopoulos MA
    Semin Hematol; 1995 Jan; 32(1):20-30. PubMed ID: 7878475
    [No Abstract]   [Full Text] [Related]  

  • 13. Using aspirates for multiple myeloma research probably excludes important data.
    Ely S
    Br J Haematol; 2006 Jul; 134(2):245-6. PubMed ID: 16846488
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow plasma cell microaggregates detected by immunohistology predict earlier relapse in patients with minimal disease after high-dose therapy for myeloma.
    Wei A; Westerman D; Feleppa F; Trivett M; Juneja S
    Haematologica; 2005 Aug; 90(8):1147-9. PubMed ID: 16079123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: unusual presentation as mono-articular arthritis.
    Chatterjee A; Roy AS; Ghosh MK
    J Indian Med Assoc; 1997 Apr; 95(4):113-5. PubMed ID: 9357275
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple myeloma.
    Singhal S; Mehta J
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1322-30. PubMed ID: 17699365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of plasma cell propidium iodide and annexin-V indices and their mutual ratio in multiple myeloma.
    Scudla V; Ordeltova M; Minarik J; Dusek L; Zemanova M; Bacovsky J
    Neoplasma; 2006; 53(3):213-8. PubMed ID: 16652190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of multiple myeloma with multilobated plasma cell nuclei.
    Invernizzi R; Perfetti V
    Haematologica; 1998 Sep; 83(9):851. PubMed ID: 9825581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.